CUSIP: 464286632
Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / MSCI ISRAEL ETF
-
Total 13F shares
-
619,773
-
Share change
-
+55,957
-
Total reported value
-
$37,631,613
-
Price per share
-
$60.71
-
Number of holders
-
75
-
Value change
-
+$3,220,842
-
Number of buys
-
35
-
Number of sells
-
27
Security key
464286632
Report period
Q2 2024
Institutions
75
Top holders
10
Reporting periods
Holder history for CUSIP 464286632
Recent filing periods:
Top shareholders of EIS - ISHARES INC - MSCI ISRAEL ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ISHARES INC - MSCI ISRAEL ETF (EIS) as of Q2 2024
As of 30 Jun 2024,
ISHARES INC - MSCI ISRAEL ETF (EIS) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
619,773 shares.
The largest 10 holders included
JANE STREET GROUP, LLC, MORGAN STANLEY, Swiss Life Asset Management Ltd, Korea Investment CORP, NEPC LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GOLDMAN SACHS GROUP INC, Equitable Holdings, Inc., BANK OF AMERICA CORP /DE/, and CITADEL ADVISORS LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor |
Q1 2024 Shares |
Q2 2024 Shares |
Share Diff |
Share Chg % |
Q1 2024 Value $ |
Q2 2024 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.